Phosphorylation of MKK3 (p-MKK3) is increased in the NAFLD mouse liver, and melatonin alleviates NAFLD phenotypes such as body weight gain, hepatic lipid accumulation, and fibrosis by inhibiting p-MKK3 expression 23. This evidence concerns the gene MAP2K3 and metabolic dysfunction-associated steatotic liver disease.